Temozolomide in Treating Patients With Invasive Pituitary Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00601289
Recruitment Status : Withdrawn (funding term ended)
First Posted : January 28, 2008
Last Update Posted : July 31, 2012
National Cancer Institute (NCI)
Information provided by:
Jonsson Comprehensive Cancer Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : October 2010
  Study Completion Date : No date given